Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinkang Capsules is a Traditional Chinese Medicine (TCM) formulation developed by the Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine. It is currently being evaluated as an adjunctive therapy to conventional Western medicine for the treatment of chronic heart failure with preserved ejection fraction (HFpEF). The drug is designed to address specific regional TCM syndrome patterns identified in the Inner Mongolia region. As a multi-component herbal preparation, it likely functions through pleiotropic effects including the improvement of myocardial energy metabolism, reduction of systemic inflammation, and modulation of cardiac remodeling, although its precise molecular targets are characteristic of the complex pharmacology found in botanical extracts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xinkang Capsules.